66 Results from the AURORA Study: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Bitopertin in Erythropoietic Protoporphyria
Year: 2025
Type: article
Institutions: Harvard University, Massachusetts General Hospital, University of Washington, Fred Hutch Cancer Center, Atrium Health Wake Forest Baptist, Wake Forest University, The University of Texas Medical Branch at Galveston, Icahn School of Medicine at Mount Sinai, University of Miami, University of California, San Francisco, University of Alabama at Birmingham, Disc Medicine, Inc. (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4416073706
